Bristol Myers Squibb Trial Fatality Raises Safety Alarms for Autoimmune CAR-T

By Elaine Chen · STAT News · 2026-10-23

STAT News reports that a patient participating in a Phase 1 study for multiple sclerosis died after receiving a Bristol Myers Squibb cell therapy. The individual developed septic pneumonia following heavy immunosuppression used to manage persistent motor symptoms. This incident m

STAT News reports that a patient participating in a Phase 1 study for multiple sclerosis died after receiving a Bristol Myers Squibb cell therapy. The individual developed septic pneumonia following heavy immunosuppression used to manage persistent motor symptoms. This incident m